Basic Information
Basic information for LINC00662-264-53aa
Peptide Name LINC00662-264-53aa
Genome Position chr19:27715691-27715849[-]
Species Human
Peptide Sequence MLCNVCIYLTELNHCFDSSVWKQFLCRIYEGTFQRPLRPIIKKQISHNKTRNI
Peptide Length 53
Unique No (LINC00662-207-53aa,LINC00662-210-53aa,LINC00662-214-53aa,LINC00662-225-53aa,LINC00662-240-53aa,LINC00662-254-53aa,LINC00662-256-53aa)
Grand Average of Hydropathicity -0.2245
Relative Molecular Mass 7337.44
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000261824;LINC00662
Transcript ID/Name ENST00000667396;LINC00662-264
Transcript Length 1110
Coding Ability 0.3577
DNA Sequence Corresponding to Peptide ATGCTTTGCAATGTGTGTATTTATCTCACAGAGTTAAACCATTGTTTTGATTCATCAGTTTGGAAACAGTTTCTTTGTAGAATCTATGAAGGGACCTTTCAGAGGCCATTGAGGCCTATAATAAAGAAACAAATATCCCACAATAAAACAAGAAACATA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :